Diodes Incorporated (NASDAQ:DIOD) a leading global manufacturer and supplier of high-quality application specific standard products within the broad discrete, logic and analog semiconductor markets, today announced that the Company will present at the Wells Fargo Securities Technology, Media & Telecom Conference to be held at The Waldorf Astoria in New York City. Laura Mehrl, Director of Investor Relations, is scheduled to host a fireside chat at 3:50 p.m. Eastern Time on Wednesday, November 12, 2014, and will be available to meet with investors throughout the day. Diodes Incorporated (NASDAQ:DIOD) belongs to Technology sector. Its net profit margin is 5.50% and weekly performance is 9.43%. On last trading day company shares ended up $25.89. Diodes Incorporated (NASDAQ:DIOD) distance from 50-day simple moving average (SMA50) is 6.89%.Atmel® Corporation (NASDAQ:ATML), a leader in microcontroller (MCU) and touch technology solutions, today announced the company is unveiling a number of new solutions to enable smart, connected and secure devices in the Internet of Things (IoT) from consumer to industrial, automotive and Maker applications at Electronica 2014 held in Munich, Germany, November 11-14. Atmel is also showcasing a number of IoT solutions in its booth located in Hall A5, Booth 542. Atmel Corporation (NASDAQ:ATML) shares increased 0.54% in last trading session and ended the day at $7.46. ATML Gross Margin is 44.30% and its return on assets is 3.40%. Atmel Corporation (NASDAQ:ATML) quarterly performance is -13.05%.Celldex Therapeutics, Inc. (NASDAQ:CLDX) on Sept. 30 announced the publication of two papers highlighting early studies of glembatumumab vedotin in breast cancer and metastatic melanoma in the Journal of Clinical Oncology (JCO). The papers, “A Phase 1/2 Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients with Advanced Melanoma” and “A Phase 1/2 Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients with Locally Advanced or Metastatic Breast Cancer” have been published as Early Release Articles on JCO’s website and will appear in a future print edition. On 03 November, Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares fell -0.36% and was closed at $16.69. CLDX EPS growth in last 5 year was 21.10%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) year to date (YTD) performance is -31.06%.Regional Management Corp (NYSE:RM) last issued its quarterly earnings data on Thursday, October 30th. The company reported $0.14 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.48 by $0.34. On average, analysts predict that Regional Management Corp will post $1.24 earnings per share for the current fiscal year. Regional Management Corp. (NYSE:RM) ended the last trading day at $11.73. Company weekly volatility is calculated as 6.64% and price to cash ratio as 41.41. Regional Management Corp. (NYSE:RM) showed a weekly performance of -30.96%.Niwot-based shoe company Crocs Inc. (NASDAQ:CROX) posted slightly higher net income in the third quarter, following a restructuring announcement at the end of second quarter. Crocs (Nasdaq: CROX) increased its net income to $15 million in the third quarter, compared with $13 million in the third quarter of 2013. Net income per common share decreased by 3 cents to 12 cents from 15 cents year-over-year in the third quarter. Revenue at the company increased 4 percent to $302 million in the third quarter. Crocs, Inc. (NASDAQ:CROX) shares fell -1.20% in last trading session and ended the day at $11.54. CROX Gross Margin is 50.60% and its return on assets is -3.20%. Crocs, Inc. (NASDAQ:CROX) quarterly performance is -28.37%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
